Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 539 results found. Search for [ Generic drugs ]

Results 1 to 21 of 539
Reuters
July 17, 2019
The U.S. Food and Drug Administration (FDA) said it found adulteration and \"significant violations\" of current good manufacturing practice (CGMP) regulations at Strides Pharma Sciences Ltd's plant in Puducherry in south India.


E Kumar Sharma
New Delhi, July 8, 2019
The path to product and profitability for stem cell players is fraught with challenges


E Kumar Sharma
June 24, 2019
This plant had five USFDA inspections between March 2015 and September 2018 with no observations and receiving an EIR after each inspection visit


PTI
Beijing, June 21, 2019
India for long has been pressing China to open its huge pharmaceutical market, which is under pressure from the public for the high prices for cancer and generic drugs


PTI
June 21, 2019



PTI
June 16, 2019



PTI
June 10, 2019



BusinessToday.In
New Delhi, June 7, 2019
Aurobindo says the case appears to be devoid of merits and consists of baseless allegations; Aceto has sought fair compensation from the Indian drugmaker


PTI
June 3, 2019



E Kumar Sharma
New Delhi, May 23, 2019
The pharma industry is today growing at around 11 per cent per annum as compared to a high of around 15 per cent about five years ago.


PTI
May 22, 2019



E Kumar Sharma
New Delhi, May 16, 2019
Some of the generic companies, it points out, made unsolicited bids to customers of bigger players in cases where drug prices were high as a way to compete with a bigger generic player to grab a bigger share in the market. Interestingly, this exercise seems to have elements of attempts at trying to drive down prices to gain customers.


PTI
May 15, 2019



BusinessToday.In
New Delhi, May 15, 2019
After Cognizant, IBM India fires 300 employees from services divisionTech behemoth IBM India has reportedly fired nearly 300 employees from its services division as it looks to \"re-invent\" its operations and fulfill the changing demand of the customers. The US-based IT major let these employees go as it focuses on emerging technology like Artificial Intelligence and reduces exposure to traditional services. US pharma scandal: Indian firm Glenmark may face a penalty of up to $873 millio...


PTI
New Delhi, May 15, 2019
These European companies are circumventing the FDA's safety requirements and placing the lives of women and their children at risk, the lawmakers said in a letter to Acting FDA Commissioner Norman Sharpless


PTI
May 14, 2019
In separate clarifications to stock exchanges, the companies denied the accusations and stated they would defend themselves in the matter


PTI
May 14, 2019



Mudit Kapoor
May 14, 2019
Severe penalties could be levied on the Indian pharma companies varying from $13 million to $873 million; Glenmark could face the highest penalty, while Aurobindo the least.


PTI
May 14, 2019



PTI
May 14, 2019



PAGES 1 OF 27  12345